Results - Announcements
Astec Lifesciences Ltd share price declined by 1.40% to Rs 655.0 after the company's net profit surged by 99.89% to Rs 37.4 crore, while revenue from operations slipped 13.81% to Rs 72.02 crore in Q3FY26 over Q2FY26.
The market capitalization of Pesticides & Agrochemicals industry group stocks on BSE stood at Rs 1.84 lakh crore, nosediving by 29.41%. It has slipped by 10.12% over last one week and tumbled 24.75% in last one month while the market capitalization of Astec Lifesciences Ltd has eased by 6.46% and 1.95% in the same period respectively.
Profit before tax (PBT) of Astec Lifesciences Ltd stood at Rs 37.43 crore in Q3 FY26, expanding by 53.34% year-on-year, and jumping 99.73% quarter-on-quarter. EBITDA came in at Rs 20 crore, rallying 161.33% YoY and surging by 1368.35% sequentially.
Total expenses saw a slight increase of 8.07% to Rs 102.99 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 56.28 crore, tumbling by 26.26% YoY, while employee benefits expense was at Rs 15.11 crore, seeing a marginal contraction of 5.56% YoY.
For the TTM ended FY26, revenue from operations improved 17.53% to Rs 448.15 crore, while net profit tanked by 39.96% to Rs 80.88 crore, compared to previous TTM. EBITDA plunged by 7163% to Rs 9.6 crore, and PBT collapsed by 42.55% to Rs 81.0 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 80.71 crore in FY26, as against Rs 8.4 crore in FY25.
Astec Lifesciences Ltd softened by 0.80% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 13.18% during the same period.